X T L Biopharmaceuticals reported $-255K in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Bioline Rx USD -977K 2.96M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
X T L Biopharmaceuticals USD -255K 298K Dec/2024